Sean Wieland
Stock Analyst at Piper Sandler
(1.80)
# 3,314
Out of 5,146 analysts
31
Total ratings
45.45%
Success rate
1.29%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $41.93 | +31.17% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $24.91 | +44.52% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $5.75 | +1,986.96% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $15.60 | -61.54% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $25.10 | +75.30% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $170.64 | +35.37% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $5.35 | +5,339.25% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $41.93
Upside: +31.17%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $24.91
Upside: +44.52%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $5.75
Upside: +1,986.96%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $15.60
Upside: -61.54%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $25.10
Upside: +75.30%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $170.64
Upside: +35.37%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $5.35
Upside: +5,339.25%